Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus.
about
Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse geneticsConnecting the study of wild influenza with the potential for pandemic diseaseAvirulent Avian influenza virus as a vaccine strain against a potential human pandemic.Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.Influenza Virus Infection of Marine Mammals.Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.Characterization of avian influenza viruses isolated from domestic ducks in Vietnam in 2009 and 2010.Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.Potency of a vaccine prepared from A/swine/Hokkaido/2/1981 (H1N1) against A/Narita/1/2009 (H1N1) pandemic influenza virus strainA novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges.Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.Live bivalent vaccine for parainfluenza and influenza virus infections.Infectivity-enhancing antibodies to Ebola virus glycoprotein.Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines.Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles.Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection.Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation.A replication-incompetent PB2-knockout influenza A virus vaccine vector.Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro.Cleavage of influenza A virus H1 hemagglutinin by swine respiratory bacterial proteases.Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.Posttranslational oligomerization and cooperative acid activation of mixed influenza hemagglutinin trimers.Changing patterns of h6 influenza viruses in Hong Kong poultry markets.A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.Seroepidemiological evidence of avian influenza A virus transmission to pigs in southern China.Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidaseEvaluation of truncated LipL32 expressed by Escherichia coli and Pichia pastoris for serodiagnosis of Leptospira infection in rodents.A novel M2e-multiple antigenic peptide providing heterologous protection in mice.Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin.Antigenic comparisons of swine-influenza-like H1N1 isolates from pigs, birds and humans: an international collaborative study.Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections.Antigenic structure of the influenza B virus hemagglutinin: nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies.Direct role of viral hemagglutinin in B-cell mitogenesis by influenza viruses.Antigenic structure and variation in an influenza virus N9 neuraminidase.PB2 protein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigsLaboratory characterization of a swine influenza virus isolated from a fatal case of human influenza
P2860
Q24607062-5DF1027E-42CD-458B-BCEF-90B4A2FB72ACQ27027237-0187BD9E-3FD5-4B9B-BA59-3D40F9DE34C5Q30322954-143D072E-6200-46C0-9B70-91A099C60E4DQ30366819-844BFDC8-8FC1-4797-B91A-3807D9B70795Q30366907-340D40AD-CA6D-4872-9244-D1550FE081ACQ30372021-F0B58D82-5ED6-499C-B62A-974C5770034EQ30409201-05D3BC99-11E5-4C08-B13B-CAA97B21F797Q30423481-87072006-B6B1-4712-A5CE-ABB8E83D9FD1Q30426820-C806DA9C-1344-44C0-9B55-6F9EE90477FCQ30430275-D30D7B57-5961-4648-A072-04AE4DDF6FE9Q33419836-BE53E852-703E-4B78-A14B-DFE4074F4D96Q33578748-2FFEC8D3-8B9A-4276-925B-828727F80DFEQ33788756-8DCA402B-CF0F-4294-AFD2-D45A1F61E921Q33850720-DD798378-F9C6-4B12-ACAC-22478091E7F5Q33944041-8474B7DB-CD1B-43F6-B815-28330BA58AB6Q34357182-FC9FF3F1-5D0A-4815-AFED-CDC633151CA2Q34359863-89ECB311-28A6-4BA8-A2F9-C40A8EF10949Q34594671-A4160195-26B4-49D7-B194-D103440DFEC2Q35104829-6167219E-7CCF-4895-BF94-344100593AFFQ35854110-469D47F4-2189-47FE-8876-0EB598CC7FEEQ35868034-EB73AFC8-A519-4F31-8D05-C56EB14A4786Q35882085-895D961C-EF50-4F73-B4C9-071C6CBF0616Q35886309-C1BFA39B-2097-4CE1-A5BC-75D813751994Q35895619-27F727F9-DD73-402F-98DD-8DF640F91C5FQ36017724-A5072FF9-5E17-4B65-B58E-0DE2BC9D4B24Q36218773-6E49EC34-62E6-403E-9507-C54D43A53D6AQ36248259-CE1AE536-DB03-4769-A9C2-4915181836FCQ36306944-D4FF53F3-8C10-451F-BB05-A0814040D4F4Q36559128-A13EFEB4-C652-46C4-8F01-D09B0CAB3DDCQ36629944-863B4F0C-28B0-4D91-85CF-4736D2D8C9E1Q36669846-14DD599C-DE04-4599-A983-ACC9994EC919Q36731466-6F8F4A2E-E12D-492E-8D27-85FEDB6F3B9CQ36867230-7A1D7716-66FD-4ECD-BA98-CE6D6BCA3B37Q36875530-634E47EC-D295-4A94-B4CE-B573CD4409B5Q36879330-565A9677-E7D6-435A-B969-4161D763B568Q36896786-34B0CE51-2795-487D-9E11-EBDA8E01E3C5Q36907127-4E801510-52D8-4549-A004-1B95483BFBB4Q36918787-6CAD3447-C29A-449B-98D8-FB6230B633BEQ37099830-BAF61F20-62CE-4D38-90E1-7EB248F972EBQ37175745-A21652D5-4647-425C-9ECA-0E3668BB9710
P2860
Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Biological activity of monoclo ...... s/1/80 (H7N7) influenza virus.
@en
Biological activity of monoclo ...... e of A/Seal/Massachusetts/1/80
@nl
type
label
Biological activity of monoclo ...... s/1/80 (H7N7) influenza virus.
@en
Biological activity of monoclo ...... e of A/Seal/Massachusetts/1/80
@nl
prefLabel
Biological activity of monoclo ...... s/1/80 (H7N7) influenza virus.
@en
Biological activity of monoclo ...... e of A/Seal/Massachusetts/1/80
@nl
P2093
P1433
P1476
Biological activity of monoclo ...... s/1/80 (H7N7) influenza virus.
@en
P2093
P356
10.1016/0042-6822(82)90375-0
P407
P577
1982-10-01T00:00:00Z